Loading company…
Vortex Biotech develops microfluidic technology to isolate circulating tumor cells from blood.
Founded in 2022, Vortex Biotech is a University of California, Los Angeles spin-out based in England, with offices in the UK and US. It develops a microfluidic chip that extracts intact, label-free circulating tumor cells from blood for cancer research and clinical use. In June 2023, EMV Capital led GBP 3.2 million in venture funding. CEO Paul Jones led the company as of that month.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in